Accelerated epigenetic aging in suicide attempters uninfluenced by high intent-to-die and choice of lethal methods.
Journal
Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664
Informations de publication
Date de publication:
02 06 2022
02 06 2022
Historique:
received:
15
02
2022
accepted:
25
05
2022
revised:
19
05
2022
entrez:
2
6
2022
pubmed:
3
6
2022
medline:
7
6
2022
Statut:
epublish
Résumé
Suicide attempts (SA) are associated with excess non-suicidal mortality, putatively mediated in part by premature cellular senescence. Epigenetic age (EA) estimators of biological age have been previously demonstrated to strongly predict physiological dysregulation and mortality risk. Herein, we investigate if violent SA with high intent-to-die is predictive of epigenetics-derived estimates of biological aging. The genome-wide methylation pattern was measured using the Illumina Infinium Methylation EPIC BeadChip in whole blood of 88 suicide attempters. Subjects were stratified into two groups based on the putative risk of later committed suicide (low- [n = 58] and high-risk [n = 30]) in dependency of SA method (violent or non-violent) and/or intent-to-die (high/low). Estimators of intrinsic and extrinsic EA acceleration, one marker optimized to predict physiological dysregulation (DNAmPhenoAge/AgeAccelPheno) and one optimized to predict lifespan (DNAmGrimAge/AgeAccelGrim) were investigated for associations to severity of SA, by univariate and multivariate analyses. The study was adequately powered to detect differences of 2.2 years in AgeAccelGrim in relation to SA severity. Baseline DNAmGrimAge exceeded chronological age by 7.3 years on average across all samples, conferring a mean 24.6% increase in relation to actual age. No individual EA acceleration marker was differentiated by suicidal risk group (p > 0.1). Thus, SA per se but not severity of SA is related to EA, implicating that excess non-suicidal mortality in SA is unrelated to risk of committed suicide. Preventative healthcare efforts aimed at curtailing excess mortality after SA may benefit from acting equally powerful to recognize somatic comorbidities irrespective of the severity inherent in the act itself.
Identifiants
pubmed: 35654772
doi: 10.1038/s41398-022-01998-8
pii: 10.1038/s41398-022-01998-8
pmc: PMC9163048
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
224Informations de copyright
© 2022. The Author(s).
Références
Arch Suicide Res. 2015;19(4):500-9
pubmed: 25879375
Clin Epigenetics. 2022 Jan 3;14(1):1
pubmed: 34980250
Nat Rev Genet. 2018 Jun;19(6):371-384
pubmed: 29643443
Prog Neuropsychopharmacol Biol Psychiatry. 2020 Mar 2;98:109805
pubmed: 31707091
Cancer Causes Control. 2015 Mar;26(3):501-9
pubmed: 25663573
Aging (Albany NY). 2021 Jun 3;13(11):14604-14629
pubmed: 34083497
Acta Psychiatr Scand. 2018 Apr;137(4):287-295
pubmed: 29238963
Int J Mol Sci. 2020 Jan 28;21(3):
pubmed: 32012861
Annu Rev Clin Psychol. 2014;10:425-48
pubmed: 24313570
World Psychiatry. 2014 Jun;13(2):153-60
pubmed: 24890068
Aging (Albany NY). 2018 Apr 18;10(4):573-591
pubmed: 29676998
EBioMedicine. 2018 Jan;27:123-133
pubmed: 29277323
Mol Cell. 2013 Jan 24;49(2):359-367
pubmed: 23177740
Clin Epigenetics. 2020 Apr 5;12(1):52
pubmed: 32248841
Am J Psychiatry. 2005 Feb;162(2):304-10
pubmed: 15677595
Curr Opin Psychiatry. 2019 Sep;32(5):381-387
pubmed: 31145144
NPJ Precis Oncol. 2019 Jan 28;3:3
pubmed: 30701196
Psychoneuroendocrinology. 2009 Nov;34(10):1526-32
pubmed: 19525070
BMC Psychiatry. 2015 Aug 14;15:196
pubmed: 26271258
Arch Gen Psychiatry. 1981 Jun;38(6):631-6
pubmed: 6166274
Mol Psychiatry. 2021 Sep;26(9):4999-5009
pubmed: 32382136
Genome Biol. 2015 Jan 30;16:25
pubmed: 25633388
Aging (Albany NY). 2016 Sep 28;8(9):1844-1865
pubmed: 27690265
JAMA Psychiatry. 2014 Feb;71(2):119-27
pubmed: 24306041
Aging (Albany NY). 2019 Jan 21;11(2):303-327
pubmed: 30669119
Cardiol Res. 2018 Feb;9(1):22-27
pubmed: 29479382
Synth Proj Res Synth Rep. 2011 Feb;(21):1-26
pubmed: 21675009
Circulation. 2019 Sep 10;140(11):e596-e646
pubmed: 30879355
Am J Geriatr Psychiatry. 2015 Jul;23(7):709-25
pubmed: 25959921
J Affect Disord. 2012 Jan;136(1-2):167-171
pubmed: 21144592
Sci Rep. 2019 Dec 4;9(1):18290
pubmed: 31797972
Genome Biol. 2013;14(10):R115
pubmed: 24138928
Transl Psychiatry. 2020 May 4;10(1):129
pubmed: 32366819
Eur Neuropsychopharmacol. 2018 Feb;28(2):243-251
pubmed: 29254658
J Affect Disord. 2021 Dec 1;295:1032-1039
pubmed: 34706411